Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Ultragenyx Pharmaceutical Inc. (RARE) - free report >>
Eagle Pharmaceuticals, Inc. (EGRX) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ultragenyx Pharmaceutical Inc. (RARE) - free report >>
Eagle Pharmaceuticals, Inc. (EGRX) - free report >>
Image: Bigstock
New Strong Sell Stocks for June 18th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Orbital Energy Group, Inc. provides electric power and solar infrastructure, and integrated energy infrastructure solutions and services. The Zacks Consensus Estimate for its current year earnings has been revised 55.5% downward over the last 30 days.
GrafTech International Ltd. (EAF - Free Report) researches, develops, manufactures, and sells graphite and carbon-based products. The Zacks Consensus Estimate for its current year earnings has been revised 4.1% downward over the last 30 days.
Ultragenyx Pharmaceutical Inc. (RARE - Free Report) is a biopharmaceutical company that focuses on the development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 21.3% downward over the last 60 days.
Eagle Pharmaceuticals, Inc. (EGRX - Free Report) is a biotechnology pharmaceutical company that focuses on developing and commercializing injectable products. The Zacks Consensus Estimate for its current year earnings has been revised 5.6% downward over the last 60 days.
TELA Bio, Inc. (TELA - Free Report) is a medical technology company that focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The Zacks Consensus Estimate for its current year earnings has been revised 5.9% downward over the last 60 days.
View the entire Zacks Rank #5 List.